https://www.selleckchem.com/pr....oducts/gilteritinib-
sis and treatment. Although adjuvant chemoradiotherapy (CRT) used to be recommended as a standard of care for locally advanced gastric cancer, this suggestion has been strongly challenged recently. However, clear evidence regarding the optimization of radiotherapy is lacking. The purpose of this study was to compare the effectiveness of preoperative CRT that of postoperative CRT for resectable or potentially resectable gastric cancer. From January 2005 to December 2017, patients with clinical stage III/IVa ( , T3-4aN+M0 or